6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide

C129H129Cl6F5N30O16 — CID 158432158

About 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide

6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide (PubChem CID 158432158) has the molecular formula C129H129Cl6F5N30O16 and a molecular weight of 2663.35 g/mol. Its IUPAC name is 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide.

Molecular Properties

• Compound Name: 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
• PubChem CID: 158432158
• Molecular Formula: C129H129Cl6F5N30O16
• Molecular Weight: 2663.35 g/mol
• Exact Mass: 2658.83
• IUPAC Name: 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide
• SMILES: CNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.COCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cc1nc2c(cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n2CC(=O)N2CC(C)(F)C2)c2c1nc(C)n2C.Cn1c(CC2CCC2)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.Cn1c(CCl)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21
• InChI: InChI=1S/C29H30ClFN6O3.C26H26ClFN6O4.C26H26ClFN6O3.C25H23Cl2FN6O3.C23H24ClFN6O3/c1-29(31)15-36(16-29)24(38)14-37-26-20(25-22(13-32-26)34-23(35(25)2)10-17-4-3-5-17)11-21(28(37)40)27(39)33-12-18-6-8-19(30)9-7-18;1-26(28)13-33(14-26)21(35)11-34-23-17(22-19(10-29-23)31-20(12-38-3)32(22)2)8-18(25(34)37)24(36)30-9-15-4-6-16(27)7-5-15;1-14-21-22(32(4)15(2)31-21)18-9-19(24(36)29-10-16-5-7-17(27)8-6-16)25(37)34(23(18)30-14)11-20(35)33-12-26(3,28)13-33;1-25(28)12-33(13-25)20(35)11-34-22-16(21-18(10-29-22)31-19(8-26)32(21)2)7-17(24(34)37)23(36)30-9-14-3-5-15(27)6-4-14;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13/h6-9,11,13,17H,3-5,10,12,14-16H2,1-2H3,(H,33,39);4-8,10H,9,11-14H2,1-3H3,(H,30,36);5-9H,10-13H2,1-4H3,(H,29,36);3-7,10H,8-9,11-13H2,1-2H3,(H,30,36);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33)
• InChIKey: HBUBJLXNSMEJIH-UHFFFAOYSA-N
• XLogP: 14.77
• TPSA: 540.06 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 36
• Rotatable Bonds: 31
• Heavy Atoms: 186
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2663.35
LogP ≤ 5	14.77
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	36

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?

The IUPAC name of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide (CID 158432158) is 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide.

What is the SMILES notation for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?

The canonical SMILES for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide is CNc1c(N)cnc2c1cc(C(=O)NCc1ccc(Cl)cc1)c(=O)n2CC(=O)N1CC(C)(F)C1.COCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2n1C.Cc1nc2c(cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n2CC(=O)N2CC(C)(F)C2)c2c1nc(C)n2C.Cn1c(CC2CCC2)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.Cn1c(CCl)nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c21.

What is the InChIKey of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?

The InChIKey is HBUBJLXNSMEJIH-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H30ClFN6O3.C26H26ClFN6O4.C26H26ClFN6O3.C25H23Cl2FN6O3.C23H24ClFN6O3/c1-29(31)15-36(16-29)24(38)14-37-26-20(25-22(13-32-26)34-23(35(25)2)10-17-4-3-5-17)11-21(28(37)40)27(39)33-12-18-6-8-19(30)9-7-18;1-26(28)13-33(14-26)21(35)11-34-23-17(22-19(10-29-23)31-20(12-38-3)32(22)2)8-18(25(34)37)24(36)30-9-15-4-6-16(27)7-5-15;1-14-21-22(32(4)15(2)31-21)18-9-19(24(36)29-10-16-5-7-17(27)8-6-16)25(37)34(23(18)30-14)11-20(35)33-12-26(3,28)13-33;1-25(28)12-33(13-25)20(35)11-34-22-16(21-18(10-29-22)31-19(8-26)32(21)2)7-17(24(34)37)23(36)30-9-14-3-5-15(27)6-4-14;1-23(25)11-30(12-23)18(32)10-31-20-15(19(27-2)17(26)9-28-20)7-16(22(31)34)21(33)29-8-13-3-5-14(24)6-4-13/h6-9,11,13,17H,3-5,10,12,14-16H2,1-2H3,(H,33,39);4-8,10H,9,11-14H2,1-3H3,(H,30,36);5-9H,10-13H2,1-4H3,(H,29,36);3-7,10H,8-9,11-13H2,1-2H3,(H,30,36);3-7,9H,8,10-12,26H2,1-2H3,(H,27,28)(H,29,33).

What are the key properties of 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide?

6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide has a molecular weight of 2663.35 g/mol, XLogP of 14.77, 31 rotatable bonds, 7 hydrogen bond donors, and 36 hydrogen bond acceptors.

Where does this data come from?

All data for 6-amino-N-[(4-chlorophenyl)methyl]-1-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-5-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;2-(chloromethyl)-N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-2-(cyclobutylmethyl)-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2-(methoxymethyl)-1-methyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide;N-[(4-chlorophenyl)methyl]-6-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-1,2,4-trimethyl-7-oxoimidazo[4,5-c][1,8]naphthyridine-8-carboxamide is sourced from PubChem (CID 158432158), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).